Stanford Chemists Develop ‘Infrared Vision’ for Cancer Immunotherapy

Date posted
Funding Agency
(Funded by the National Institutes of Health)

Researchers at Stanford University have developed nanoparticles that can be used to light up and image tumors located well below the surface of the skin. The nanoparticles should be useful for not only diagnosing and monitoring tumor progression but also for predicting how individual patients will respond to a given immunotherapy.